Paul Silva - Vertex Pharmaceuticals Insider

Vertex Pharmaceuticals Incorporated -- USA Stock  

USD 141.68  1.93  1.34%

Senior Vice President Corporate Controller

Mr. Paul M. Silva is Senior Vice President and Corporationrationrate Controller of Vertex Pharmaceuticals Incorporated. Mr. Silva is our Senior Vice President and Corporationrationrate Controller, a position he has held since April 2011. Mr. Silva joined us in August 2007 as Senior Director, Accounting Operations and was our Vice President and Corporationrationrate Controller from September 2008 through April 2011. Prior to joining us, he was the Vice President, Internal Reporting at Iron Mountain Incorporated from July 2006 until August 2007 and a consultant to Iron Mountains financing department from April 2005 until July 2006. He was the Finance Director of the Bioscience Technologies Division of Thermo Electron Corporationrationration from 2002 to April 2005
Age: 50  President Since 2011      
617-341-6100  www.vrtx.com
Silva holds a B.S. in accounting from Assumption College.

Paul Silva Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.6 % which means that it generated profit of $6.6 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 1.14 % meaning that it created $1.14 on every $100 dollars invested by stockholders.
The company currently holds 587.19 M in liabilities with Debt to Equity (D/E) ratio of 32.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals Incorporated has Current Ratio of 3.21 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Jaime ContrerasAbbott Laboratories
2013
Stephen FussellAbbott Laboratories
2013
Murthy SimhambhatlaAbbott Laboratories
2013
Georges VosAbbott Laboratories
2013
Thomas FrinziAbbott Laboratories
2016
Deepak NathAbbott Laboratories
2015
Ronald HuttonBio Rad Laboratories Inc
2012
Roger BirdAbbott Laboratories
2015
JeanYves PaveeAbbott Laboratories
2015
Timothy ErnstBio Rad Laboratories Inc
2016
Heather MasonAbbott Laboratories
2015
Antonio PeraEndo International plc
2016
Camille FarhatEndo International plc
2012
Scott WhiteAbbott Laboratories
2013
Shawn SoderbergBio Rad Laboratories Inc
2013
Terrance CoughlinEndo International plc
2016
Blaise ColemanEndo International plc
2016
Michael CrowleyBio Rad Laboratories Inc
2014
Charles FoltzAbbott Laboratories
2013
Michael WarmuthAbbott Laboratories
2012
Eric FainAbbott Laboratories
2017

Entity Summary

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing medicines for serious diseases. Vertex Pharmaceuticals Incorporated (VRTX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 1,950 people. Vertex Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Idea Analyzer Now
   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Hide  View All  NextLaunch Idea Analyzer
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Vertex Pharmaceuticals Incorporated to your portfolio

Top Management

Vertex Pharmaceuticals Leadership Team
Paul Silva, President
William Young, Director, MBA
David Altshuler, Director
Jeffrey Chodakewitz, President
Elaine Ullian, Director
Michael Parini, President
Alan Garber, Director, Ph.D
Amit Sachdev, President
Joshua Boger, Chairman
David Greenway, Director
Bruce Sachs, Director, MBA
Margaret McGlynn, Director, MBA
Michael Partridge, President
Yuchun Lee, Director, MBA
Sangeeta Bhatia, Director, Ph.D
Stuart Arbuckle, EVP
Thomas Graney, President, MBA
Terrence Kearney, Director, MBA
Ian Smith, President
Jeffrey Leiden, Chairman, Ph.D

Stock Performance

Vertex Pharmaceuticals Performance Indicators